Study of a new pill for type 2 diabetes during Ramadan fasting
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an oral medication called orforglipron to see if it safely helps people with type 2 diabetes manage their blood sugar while they fast during Ramadan. You may be a good fit if you are planning to fast and your diabetes is not too severe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are planning to fast during Ramadan.
- Your blood sugar (A1C) is between 7.0% and 9.4% at a recent checkup.
- Your weight has stayed about the same (within 11 pounds) in the last 3 months.
- Your BMI is 25 or higher – this is a measure of body weight for height.
- You do not have a personal or family history of a rare thyroid cancer called medullary thyroid cancer or a condition called MEN2.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new daily pill, orforglipron, compared to another injectable medicine (dulaglutide) in children and teens with type 2 diabetes. It aims to see if the new pill can improve blood sugar control with fewer injections.
This study tests whether focused video education can help people with type 2 diabetes manage their blood sugar safely while fasting during Ramadan. You will receive extra teaching and support through video calls to reduce the risk of complications.
This study compares how two types of fasting—traditional Ramadan dry fasting and a 16-hour daily fasting schedule—affect how your cells manage energy and repair themselves. Researchers want to understand if fasting triggers beneficial cleanup processes in your cells.
This study looks at how your genes affect your response to a diabetes medication called orforglipron. You will stop your usual diabetes pills for 5 days, then take the study drug and have a meal test to see how your blood sugar and body respond.
This study looks at how people with type 2 diabetes manage fasting during Ramadan. Researchers want to understand your experience of fasting with your condition.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Hear when a new Glucose Metabolism Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.